Organizations Filed Purposes:
THE CORPORATION IS ORGANIZED FOR CHARITABLE AND EDUCATIONAL PURPOSES, INCLUDING: (I) PROVIDING CRITICAL PLATFORMS FOR PRESENTING NEW RESEARCH, SHARING BEST PRACTICES, AND ADVANCING THE FIGHT AGAINST AIDS; AND (II) PROMOTING DIALOGUES, EDUCATION, AND NETWORKING TO HELP CLOSE GAPS IN KNOWLEDGE AND EXPERTISE AT EVERY LEVEL OF THE RESPONSE TO AIDS.
CONFERENCES: NIH 2019 IAS GRANT: NIH GRANT 2019 ON 21-24 JULY 2019, CLOSE TO 6,000 HIV PROFESSIONALS AND COMMUNITY MEMBERS MET AT THE 10TH IAS CONFERENCE ON HIV SCIENCE (IAS 2019) IN MEXICO CITY. THE CONFERENCE HAD RETURNED TO LATIN AMERICA FOR THE FIRST TIME SINCE IT WAS HELD IN BRAZIL IN 2005. IT PRESENTED LATEST ADVANCES IN HIV SCIENCE AND DREW ATTENTION TO THE GLOBAL NEED FOR POLITICAL LEADERSHIP TO OVERCOME CUTS IN HIV FUNDING, ADVANCE A HUMAN RIGHTS LED RESPONSE TO HIV AND ADDRESS THE STRUCTURAL AND SOCIAL BARRIERS THAT CONTINUE TO IMPEDE THE RESPONSE. IAS 2019 RAISED AWARENESS OF THE CURRENT CHALLENGES FACED BY THE LATIN AMERICAN REGION WHERE HIV INCIDENCE IS RISING, LEVELS OF POPULATION MOBILITY ARE HIGH, HUMANITARIAN CRISES CONTINUE, ACCESS TO AFFORDABLE MEDICINES IS UNEVEN AND A FUNDING GAP PERSISTS. THE CARIBBEAN SHARES MANY OF THESE CHALLENGES, ALTHOUGH HIV INCIDENCE IN THE REGION HAS SHOWN AN ENCOURAGING DECLINE SINCE 2010. AS WELL AS 39 HIGH-QUALITY ABSTRACT-LED SCIENTIFIC SESSIONS OF 1,332 SUBMITTED ABSTRACTS, 35% WERE ACCEPTED FOLLOWING RIGOROUS PEER REVIEW IAS 2019 OFFERED 40 INVITED-SPEAKER SESSIONS, NINE PLENARY KEYNOTE PRESENTATIONS AND OVER 50 SATELLITE MEETINGS AND PRE-CONFERENCE MEETINGS.
GILEAD: THE GRANT OF US$ 50,000 FROM GILEAD SCIENCES SUPPORTED THE IAS TOWARDS AN HIV CURE INITIATIVE WHICH DRIVES CONCERTED EFFORTS TO ACCELERATE GLOBAL SCIENTIFIC RESEARCH AND ENGAGEMENT TOWARDS A CURE FOR HIV. IN LINE WITH THE RECOMMENDATIONS OF THE IAS GLOBAL SCIENTIFIC STRATEGY: TOWARDS AN HIV CURE 2016, A COMPREHENSIVE BLUEPRINT FOR CURE AND REMISSION RESEARCH, THE INITIATIVE FOCUSES ITS EFFORTS ON ADVANCING THE HIV CURE FIELD IN RESOURCE-LIMITED SETTINGS AND FACILITATING INTERACTION BETWEEN HIV AND OTHER BIOMEDICAL RESEARCH AREAS. SUPPORTED ACTIVITIES IN 2019 INCLUDED: (1) 2019 HIV & HBV CURE FORUM AND ASSOCIATED SCHOLARSHIP PROGRAMME, MEXICO, 20-21 JULY 2019, IMMEDIATELY PRECEDING THE 10TH IAS CONFERENCE ON HIV SCIENCE; (2) RESEARCH-FOR-CURE-ACADEMY FOR EARLY- TO MID-CAREER INVESTIGATORS, SOUTH AFRICA, 7-9 NOVEMBER 2019; (3) ADVOCACY-FOR-CURE-ACADEMY FOR ADVOCATES AND PEER EDUCATORS, BOTSWANA, 29 APRIL1 MAY 2019; (4) ADVOCACY-FOR-CURE GRANT PROGRAMME.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Helga Ying | HEAD OF OFFICE | 40 | $142,692 |
Emmanuel Flamand | DIRECTOR OF FINANCE | 1.5 | $0 |
Emily Blitz | SECRETARY | 9 | $0 |
Judith Auerbach Phd | TREASURER | 0.1 | $0 |
Adaora Adimora | VICE PRESIDENT | 0.1 | $0 |
Chris Beyrer Md Mph | PRESIDENT | 0.1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202022899349300702_public.xml